-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BYj7MZ1GeuIEGE8ro8luVDhUXGxySgSgQtFyvlXTt+X7IIbgxx87MIrdgEhWKKWm JnHvRknUl0kFpQs53zfxHA== 0000891092-00-000161.txt : 20000307 0000891092-00-000161.hdr.sgml : 20000307 ACCESSION NUMBER: 0000891092-00-000161 CONFORMED SUBMISSION TYPE: 424B1 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B1 SEC ACT: SEC FILE NUMBER: 333-45677 FILM NUMBER: 561514 BUSINESS ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2159880080 MAIL ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 424B1 1 FORM 424B1 Filed under Rule 423(b)(1) File No. 333-45677 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED APRIL 12, 1999 Prospectus Dated April, 12, 1999 Hemispherx Biopharma, Inc. 1,000,000 shares of common stock Resales by Selling Security holders The Prospectus supplement adds the name of Value Management & Research-Luxembourg to the selling securityholders table in the prospectus relating to the registration of 250,000 shares of our common stock underlying warrants. The table of the selling stockholders is also amended to delete 250,000 shares of our common stock underlying warrants incorrectly registered under the name of Value Management & Research-AG.
Securities Owned Securities Owned Prior to the Offering Securities Offered After the Offering Name of Selling Security holder Common Stock Warrants Common Stock Amount % - --------------- ------------ -------- ------------ ------ - Value Management 750,000 0 750,000 0 0 and Research AG Value Management 0 250,000 250,000 0 0 and Research Luxemborg
-----END PRIVACY-ENHANCED MESSAGE-----